Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2010 1
2012 2
2013 1
2014 1
2015 3
2016 8
2017 5
2018 6
2019 2
2020 6
2021 6
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Peffault de Latour R, et al. Among authors: barraco f. N Engl J Med. 2022 Jan 6;386(1):11-23. doi: 10.1056/NEJMoa2109965. N Engl J Med. 2022. PMID: 34986284 Clinical Trial.
Therapeutic options in VEXAS syndrome: insights from a retrospective series.
Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel CA, Lega JC, Barraco F, Sève P, Jamilloux Y, Sujobert P. Bourbon E, et al. Among authors: barraco f. Blood. 2021 Jul 1;137(26):3682-3684. doi: 10.1182/blood.2020010177. Blood. 2021. PMID: 33619558 Free article. Review. No abstract available.
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, Mékinian A, Coelho H, Fossard G, Barraco F, Galicier L, Bienvenu B, Hirsch P, Vial G, Boutin AB, Galland J, Le Guenno G, Bigot A, Warrington KJ, Kermani TA, Grayson PC, Patel BA, Beck DB, Jamilloux Y, Fenaux P, Sujobert P. Heiblig M, et al. Among authors: barraco f. Blood. 2022 Aug 25;140(8):927-931. doi: 10.1182/blood.2022016642. Blood. 2022. PMID: 35609174 Free PMC article.
Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center.
Cardillo M, Poli F, Barraco F, Fazio N, Rossini G, Boschiero L, Nocera A, Rigotti P, Marchini F, Zacchello G, Zanon G, Sandrini S, Chiaramonte S, Maresca C, Caldara R, Messa P, Berardinelli L, Ambrosini A, Montanaro D, Rampino T, Minetti E, Gotti E, Ghio L, Ginevri F, Albertario F, Scalamogna M. Cardillo M, et al. Among authors: barraco f. Contrib Nephrol. 2005;146:1-10. doi: 10.1159/000082056. Contrib Nephrol. 2005. PMID: 15567915 Review.
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.
Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, Balsat M, Scanvion Q, Hachulla E, Launay D, Yakoub-Agha I, Terriou L. Diarra A, et al. Among authors: barraco f. Blood Adv. 2022 Feb 8;6(3):998-1003. doi: 10.1182/bloodadvances.2021004749. Blood Adv. 2022. PMID: 34714914 Free PMC article.
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.
Bossard JB, Beuscart JB, Robin M, Mohty M, Barraco F, Chevallier P, Marchand T, Rubio MT, Charbonnier A, Blaise D, Bay JO, Botella-Garcia C, Damaj G, Beckerich F, Ceballos P, Cluzeau T, Cornillon J, Meunier M, Orvain C, Duhamel A, Garnier F, Kiladjian JJ, Yakoub-Agha I; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), the France-Intergroupe des Syndromes Myéloprolifératifs (FIM) and the Agence de la BioMédecine (ABM). Bossard JB, et al. Among authors: barraco f. Am J Hematol. 2021 Jan;96(1):80-88. doi: 10.1002/ajh.26034. Epub 2020 Nov 18. Am J Hematol. 2021. PMID: 33108024 Free article. Clinical Trial.
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
Sutra Del Galy A, Willems L, D'Aveni M, Pautas C, Chantepie S, Carpentier B, Barraco F, Banos A, Garidi R, Forcade E, Sicre de Fontbrune F, Peffault de Latour R. Sutra Del Galy A, et al. Among authors: barraco f. Br J Haematol. 2023 Apr;201(2):e16-e20. doi: 10.1111/bjh.18693. Epub 2023 Feb 17. Br J Haematol. 2023. PMID: 36807116 No abstract available.
Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation.
Mouton W, Conrad A, Alcazer V, Boccard M, Bodinier M, Oriol G, Subtil F, Labussière-Wallet H, Ducastelle-Lepretre S, Barraco F, Balsat M, Fossard G, Brengel-Pesce K, Ader F, Trouillet-Assant S. Mouton W, et al. Among authors: barraco f. Transplant Cell Ther. 2023 Feb;29(2):94.e1-94.e13. doi: 10.1016/j.jtct.2022.10.025. Epub 2022 Nov 3. Transplant Cell Ther. 2023. PMID: 36336259 Free article.
43 results